US 11,814,356 B1
Salt of cabozantinib
Fabio E. S. Souza, Brantford (CA); Alexander J. Stirk, Brantford (CA); Avedis Karadeolian, Brantford (CA); and Allan W. Rey, Brantford (CA)
Assigned to Apotex Inc., Toronto (CA)
Filed by Apotex Inc., Toronto (CA)
Filed on Mar. 29, 2023, as Appl. No. 18/127,726.
Int. Cl. C07D 215/233 (2006.01)
CPC C07D 215/233 (2013.01) [C07B 2200/13 (2013.01)] 16 Claims
OG exemplary drawing
 
1. A crystalline form of cabozantinib acesulfamate, characterized by a PXRD diffractogram comprising peaks, expressed in degrees 2θ (±0.2°), at 9.5°, 11.2°, and 19.7°.